To investigate whether TMEM116 expression was altered in lung cancer, we examined its expression in the clinical samples of two main subtypes of non-small-cell lung cancer (NSCLC), lung adenocarcinoma (LUAD) and lung squamous cell carcinomas (LUSC). Here, TMEM116 is linked to squamous cell lung carcinoma.